Q5119 is a valid 2023 HCPCS Code that could be used to indicate Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg for reimbursement purposes.
Q5119 belongs to Medical Care Type of Service and has been in effect since Jul 01, 2020.
Short description for Q5119 HCPCS code:
Inj ruxience, 10 mg